Fixed-dose gabapentin augmentation in the treatment of alcohol withdrawal syndrome: a retrospective, open-label study

Alex Andaluz,Dustin DeMoss,Cynthia Claassen,Somer E. Blair,Jennifer Hsu,Sulaimon A Bakre,Mehreen Khan,Folefac Atem,A. John Rush

Fixed-dose gabapentin augmentation in the treatment of alcohol withdrawal syndrome: a retrospective, open-label study

2019

Alex Andaluz
Dustin DeMoss
Cynthia Claassen
Somer E. Blair
Jennifer Hsu
Sulaimon A Bakre
Mehreen Khan
Folefac Atem
A. John Rush

ABSTRACTBackground: Lorazepam use in the treatment of alcohol withdrawal syndrome (AWS) is not without risk.Objective: This study compares AWS outcomes using a standard, symptom-triggered lorazepam...

Keywords:

Lorazepam
Anesthesia
Alcohol withdrawal syndrome
Dose gabapentin
Gabapentin
Psychiatry
Medicine
fixed dose
open label study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations